Inflammation-Induced Hepatocellular Carcinoma Is Dependent on Ccr5 in Mice

Abstract

Our results indicate that CCR5 has a critical role in both the development and progression of liver cancer. Therefore, we propose that a CCR5 antagonist can serve for HCC cancer prevention and treatment.